FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine

Email not displaying correctly? View it in your browser.

June 13, 2017

PRECISION MEDICINE
FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine
From - Diagnostic Testing & Emerging Technologies
In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first…
Read More

HEALTH CARE REFORM
AACC Calls for Lab Professionals to Support Value-Based Care
From - Laboratory Industry Report
Laboratory professionals have a central role to play in supporting the transition to value-based care, according to…
Read More

EMPLOYMENT LAW
Employment Law Update for HR Managers
From - G2 Blog
This is my periodic update prepared for interested HR professionals trying to deal with the complex American employment laws…
Read More

FDA
GAO Faults U.S. Handling of Zika Outbreak; IDs Challenges to Test Development
From - National Intelligence Report
The US. Government Accountability Office (GAO) found that the U.S. Department of Health and Human Services was "reactive" in its handling of the…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Unsubscribe | Forward to a Friend